 |
(R)-6-(2-fluorophenyl)-N-(3-(2-((2-methoxyethyl)amino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Bile duct cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-19 00:00:00 |
| Sponsor | ArQule, Inc.;One Wall Street;Burlington, Massachusetts, 01803 |
